ARMISTICE CAPITAL LLC 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 5:16 pm Purchase | 2024-09-30 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | ARMISTICE CAPITAL LLC | 3,357,953 9.990% | 1,593,953 (+90.36%) | Filing |
| 2024-02-14 3:52 pm Purchase | 2023-12-31 | 13G | Reviva Pharmaceuticals Holdings, Inc. RVPH | ARMISTICE CAPITAL LLC | 1,764,000 6.320% | 1,764,000 (New Position) | Filing |